S SREENIVASA RAO's most recent trade in Gland Pharma Ltd. was a Acquisition of 2,800 Equity Shares done at an average price of Rs. 542 . Disclosure was reported to the exchange on Feb. 26, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for S SREENIVASA RAO in the Trendlyne database.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gland Pharma | S SREENIVASA RAO | Designated Person | Acquisition | 26 Feb 2025 | 2,800 | 2,850 (0%) | 0.00% | 542 | 1,517,600 | 26 Feb 2025 26 Feb 2025 |
Insider Trading | Equity Shares | ESOP |
Premier Energies | Ravella Sreenivasa Rao | KMP | Pledge | 27 Dec 2024 | 21,000 | 25,699 (0%) | 0.00% | 970 | 20,370,000 | 26 Dec 2024 26 Dec 2024 |
Insider Trading | Equity Shares | Creation Of Pledge |
Premier Energies | Ravella Sreenivasa Rao | KMP | Acquisition | 27 Dec 2024 | 21,000 | 25,699 (0%) | 0.00% | 21.3 | 447,090 | 24 Dec 2024 24 Dec 2024 |
Insider Trading | Equity Shares | ESOP |
Premier Energies | Ravella Sreenivasa Rao | KMP | Disposal | 03 Dec 2024 | 10,000 | 4,699 (0%) | 0.00% | 1231.5 | 12,315,215 | 29 Nov 2024 29 Nov 2024 |
Insider Trading | Equity Shares | Market Sale |
Gland Pharma | S.Sreenivasa Rao | Designated Person | Acquisition | 12 Jul 2021 | 2,800 | 13,900 (0.01%) | 0.00% | 542 | 1,517,600 | 05 Jul 2021 05 Jul 2021 |
Insider Trading | Equity Shares | ESOP |
Laurus Labs | SREENIVASA RAO BUDDI | Employee | Acquisition | 18 Jun 2021 | 2,457 | 42,457 (0.01%) | 0.00% | 611.3 | 1,501,890 | 17 Jun 2021 17 Jun 2021 |
Insider Trading | Equity Shares | Market Purchase |
Laurus Labs | Sreenivasa Rao Buddi | Employee | Pledge | 11 Dec 2020 | 17,000 | 40,000 (0.01%) | 0.00% | 322 | 5,474,000 | 04 Dec 2020 04 Dec 2020 |
Insider Trading | Equity Shares | Creation Of Pledge |